LifeStance (LFST) announced that its board of directors has appointed Dave Bourdon as the company’s new CEO. Bourdon, who joined LifeStance as CFO in 2022, is succeeding Ken Burdick, who is retiring from his role as CEO and will assume the role of executive chairman. Bourdon has also been appointed to serve on the board of directors. In addition, Ryan McGroarty has been appointed to serve as the company’s new CFO and brings over 25 years of health care experience, including 15 years in CFO roles. Bourdon’s appointment is effective Monday, March 3, and McGroarty’s appointment is effective Monday, March 17.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks